tirzepatide patent expiry in india Looming GLP-1 drug expirations draw generics firms Amid GLP-1 drugs going viral,

In this episode, I sit down with Lyle McDonald to break down what the science actually shows about metabolism and fat loss during the menopause transition

In 2021, the FDA approved a third semaglutide formulation, Wegovy, for chronic weight management for those with obesity or overweight and at least one weight-related condition

October 2023: A study suggested that patients with obesity who took Glucagon-like Peptide-1 Receptor Agonists (such as Ozempic) for weight loss had a higher risk of gastroparesis than those in the dataset who took bupropion-naltrexone

Therefore, its important for patients to tell their doctor about all the medications they are taking